Trials / Conditions / Locally Advanced Breast Cancer (LABC)

Locally Advanced Breast Cancer (LABC)

9 registered clinical trials studyying Locally Advanced Breast Cancer (LABC) — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Patient-Derived Organoids to Functionally Characterize Chemotherapy Resistance in Breast Cancer NCT07516626	Atlas University	—
Not Yet Recruiting	Preoperative Shoulder Exercises and Postoperative Inflammation, Pain, and Function After Modified Radical Mast NCT07420335	Indonesia University	N/A
Not Yet Recruiting	JSKN016 in Combination With D-0502 for Locally Advanced or Metastatic HR-Positive, HER2-Negative Breast Cancer NCT07336771	Jiangsu Alphamab Biopharmaceuticals Co., Ltd	Phase 1 / Phase 2
Not Yet Recruiting	Pyrotinib Maleate Tablets in Combination With Dalpiciclib Isethionate Tablets and Standard Endocrine Therapy NCT07189884	The First Affiliated Hospital of Xiamen University	Phase 1 / Phase 2
Recruiting	A Phase Ib/II Study to Evaluate Multiple Combination Therapies of FWD1802 in Patients With ER+/HER2- BC NCT07002177	Forward Pharmaceuticals Co., Ltd.	Phase 1 / Phase 2
Active Not Recruiting	A Study to Assess CLBR001+ABBV-461 in Subjects With Locally Advanced or Metastatic Breast Cancer NCT06878248	Calibr, a division of Scripps Research	Phase 1
Withdrawn	A Clinical Study to Explore the Safety, Tolerability, and Efficacy of Recombinant Human nsIL12 Oncolytic Adeno NCT07150767	Beijing Bio-Targeting Therapeutics Technology Co., Ltd	Phase 1
Completed	Blood Oxygen Level Dependent Magnetic Resonance Imaging (BOLD MRI) and Fluorothymidine Positron Emission Tomog NCT01240681	Ontario Clinical Oncology Group (OCOG)	N/A
Completed	Study to Determine the Efficacy and Safety of Docetaxel and Doxorubicin With INGN 201 in Locally Advanced Brea NCT00286247	Introgen Therapeutics	Phase 2